97064 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for hormones Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#2SUSTAINED TRANSGENE EXPRESSION OF MODIFIED ERT2 PEPTIDE-SUICIDE PROTEIN FUSION POLYPEPTIDES
#3ENGINEERING CHEMICALLY INDUCIBLE SPLIT PROTEIN ACTUATORS (CISPA)
#4Polypeptide Fragment Thyroid Hormone Receptor BETA1 (THRB)-CVD20, and Polyclonal Antibody Prepared Using the Same and Use Thereof
#5SPATIO-TEMPORAL CONTROL OF THE ACTIVITY OF A RNA-GUIDED DNA ENDONUCLEASE
#6LIVE CELL IMAGING PLATFORM FOR CONDENSATES
#7ENHANCING ESTROGEN RECEPTOR ALPHA IN OSTEOARTHRITIS
#8NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#9ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A TRANSCRIPTION FACTOR AND A HEAT SHOCK PROTEIN 90 BINDING DOMAIN
#10HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
#11GENETIC CONSTRUCT FOR TRACKING AND/OR ABLATING QUIESCENT CELLS
#12COMPOSITIONS AND METHODS FOR INDUCING ESR1, PI3K, HER2, AND HER3 IMMUNE RESPONSES
#13COMPOSITIONS AND METHODS FOR MODULATING MOLECULES
#14IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#15ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN
#16INDUCIBLE MOSAICISM
#17ERT2 MUTANTS AND USES THEREOF
#18METHODS OF MODULATING ANDROGEN RECEPTOR CONDENSATES
#19POLY-GLUTAMINE ANDROGEN RECEPTOR KNOCK-IN ANIMAL MODELS, REAGENTS AND METHODS
#20ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN
#21NOVEL ESR1 DERIVED PEPTIDES AND USES THEREOF FOR NEOANTIGEN THERAPY
#22NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#23GENE FUSIONS FOR CONTROL OF GENETICALLY MODIFIED CELLS
#24CAS9 PROTEINS INCLUDING LIGAND-DEPENDENT INTEINS
#25METHODS FOR ENGINEERING HUMAN PLURIPOTENT STEM CELLS FOR INSULIN PRODUCTION
#26COMPOSITIONS AND METHODS FOR DETECTING GENE FUSIONS OF ESR1 AND CCDC170 FOR DETERMINING INCREASED RESISTANCE TO ENDOCRINE THERAPY AND FOR CANCER TREATMENT
#27COMPOSITIONS AND METHODS FOR REGULATING IMMUNE SYSTEM ACTIVITY
#28NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#29COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF TRANSCRIPTION
#30REAL-TIME G-PROTEIN COUPLED RECEPTOR (GPCR) LINKED BIOLUMINESCENT SENSING OF BIOLOGICAL TARGETS AND PROCESSES
#31TREATMENT
#32NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#33NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#34Peptides and combination of peptides for use in immunotherapy against various cancers
#35Peptides and combination of peptides for use in immunotherapy against various cancers
#36NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#37Peptides and combination of peptides for use in immunotherapy against various cancers
#38Peptides and combination of peptides for use in immunotherapy against various cancers
#39Peptides and combination of peptides for use in immunotherapy against various cancers
#40Peptides and combination of peptides for use in immunotherapy against various cancers
#41Peptides and combination of peptides for use in immunotherapy against various cancers
#42Peptides and combination of peptides for use in immunotherapy against various cancers
#43REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#44Therapeutic Targets for Oncogenic KRAS-Dependent Cancers
#45Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer
#46COMPOSITIONS AND METHODS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS
#47METHODS FOR DIAGNOSING OR TREATING POST-TRAUMATIC STRESS DISORDER, AND COMPOSITIONS THEREFOR
#48Chimeric polypeptides and methods of altering the membrane localization of the same
#49Peptides and combination of peptides for use in immunotherapy against various cancers
#50Peptides and combination of peptides for use in immunotherapy against various cancers
#51Peptides and combination of peptides for use in immunotherapy against various cancers
#52Peptides and combination of peptides for use in immunotherapy against various cancers
#53Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#54Peptides and combination of peptides for use in immunotherapy against various cancers
#55Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#56NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#57MONOCLONAL ANTIBODY FUSIONS
#58CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#59Method of inactivating a glucocorticoid receptor gene in an isolated cell
#60CAS9 proteins including ligand-dependent inteins
#61HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
#62Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#63Variant Cas9 polypeptides comprising internal insertions
#64Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#65Peptides and combination of peptides for use in immunotherapy against various cancers
#66Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#67Peptides and combination of peptides for use in immunotherapy against various cancers
#68Chemical-inducible genome engineering technology
#69Methods for enhancing the pluripotency of stem cells
#70Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#71Systems and methods for determining a treatment course of action
#72Peptides and combination of peptides for use in immunotherapy against various cancers
#73Peptides and combination of peptides for use in immunotherapy against various cancers
#74Methods for generating universal and custom MHC/HLA-compatible hematopoietic progenitor cells
#75CAS9 proteins including ligand-dependent inteins
#76HER-1, HER-3 and IGF-1R compositions and uses thereof
#77Genetically-mutated bacterial strain for detecting estrogenic compound and method for detecting estrogenic compound using the same
#78Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#79Step-function channelrhodopsins for optical control of cells
#80Novel Substitution Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System
#81Peptides and combination of peptides for use in immunotherapy against various cancers
#82Human ARCAP transgenic mouse
#83Peptides and combination of peptides for use in immunotherapy against various cancers
#84Peptides and combination of peptides for use in immunotherapy against various cancers
#85Chimeric polypeptides and methods of altering the membrane localization of the same
#86Poly-glutamine androgen receptor knock-in mouse models, reagents and methods
#87Anti-androgen peptides and uses thereof in cancer therapy
#88Chimeric antigen receptors with integrated controllable functions
#89REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#90Use of chimeric antigen receptor modified cells to treat cancer
#91Methods of using chimeric receptors to identify autoimmune disease
#92MULTIPLEX ALLELE SPECIFIC PCR ASSAYS FOR DETECTION OF ESTROGEN RECEPTOR ESR1 MUTATIONS
#93CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#94CAS9 proteins including ligand-dependent inteins
#95NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#96Peptides and combination of peptides for use in immunotherapy against various cancers
#97Peptides and combination of peptides for use in immunotherapy against various cancers
#98Peptides and combination of peptides for use in immunotherapy against various cancers
#99Peptides and combination of peptides for use in immunotherapy against various cancers
#100Peptides and combination of peptides for use in immunotherapy against various cancers
#101Peptides and combination of peptides for use in immunotherapy against various cancers
#102Ultrasensitive androgen receptor bioassay
#103Peptides and combination of peptides for use in immunotherapy against various cancers
#104Androgen receptor antagonists
#105Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System
#106Novel Ecdysone Receptor/Invertebrate Retinoid X Receptor-Based Inducible Gene Expression System
#107Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#108Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
#109Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#110SMALL MOLECULE-DEPENDENT INTEINS AND USES THEREOF
#111Isolated human cell with an inactivated glucocorticoid receptor gene
#112HER-1, HER-3 and IGF-1R compositions and uses thereof
#113Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#114Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
#115Methods of using chimeric receptors to identify autoimmune disease
#116IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#117Methods and compositions for determining resistance to androgen receptor therapy
#118Anti-androgen peptides and uses thereof in cancer therapy
#119Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System
#120Systems and methods for determining a treatment course of action
#121Aptamer modulators of estrogen receptors
#122Compositions for enhancing the pluripotency of stem cells
#123COMPOSITIONS AND METHODS FOR AUDITORY THERAPY
#124Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#125ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF
#126Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
#127Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#128METHOD AND COMPOSITIONS FOR MONITORING DNA BINDING MOLECULES IN LIVING CELLS
#129COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER
#130METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER
#131Methods of using chimeric receptors to identify autoimmune disease
#132Methods for intracellular delivery of nucleic acids
#133Estrogen receptors and methods of use
#134Estrogen receptors and methods of use
#135Estrogen receptors and methods of use
#136NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#137SCREENING METHOD
#138Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
#139Human androgen receptor alternative splice variants
#140COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING NEOPLASIA
#141Method for controlling the biological activity of a protein in a vertebrate cell
#142GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF
#143Estrogen receptors and methods of use
#144NUCLEAR RECEPTOR SENSOR SYSTEM IN TRANSGENIC ANIMAL
#145Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
#146BIOLOGICAL APPLICATIONS OF STEROID BINDING DOMAINS
#147Association of the progesterone receptor with fertility
#148Fusion protein comprising a Caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
#149Method for the administration of anti-cancer drugs
#150TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO
#151USE OF ESTROGEN AND ANDROGEN BINDING PROTEINS IN METHODS AND COMPOSITIONS FOR TREATING GYNAECOLOGICAL CANCERS
#152Phosphorylation of histone H3 at threonine 11—a novel epigenetic mark for transcriptional regulation
#153Antibody that binds to ER-α36
#154Multiple inducible gene regulation system
#155Knockin mouse with a disruption in a PXR gene expressing human PXR
#156Transgenic mice for assessing drug metabolism and toxicity
#157ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY
#158METHODS AND COMPOSITIONS IN BREAST CANCER THERAPY RESISTANCE
#159METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER
#160Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
#161Non-androgen dependent roles for androgen receptor in liver cancer
#162Prostate Epithelial Androgen Receptor Suppresses Prostate Growth and Tumor Invasion
#163Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)
#164Single-molecule-format probe and utilization thereof
#165Conditionally-Immortalised Pancreatic Cells
#166Chimeric protein comprising a green fluorescent ptotein fused to a transcription factor
#167Single molecule-format real-time bioluminescence imaging probe
#168MULTICOLOR BIOLUMINESCENT VISUALIZATION PROBE SET, OR SINGLE-MOLECULE-FORMAT MULTICOLOR BIOLUMINESCENT VISUALIZATION PROBE
#169Estrogen receptor genes and utilization thereof
#170Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#171Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target
#172Estrogen receptor intramolecular folding systems, estrogen receptor intramolecular folding sensors, methods of use thereof, methods of detecting ER ligands, and methods of detecting ER agonists and antagonists
#173METHODS FOR SCREENING INSECTICIDES
#174CHARACTERIZATION OF A MEMBRANE ESTROGEN RECEPTOR
#175Ligand activated transcriptional regulator proteins
#176Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#177Non-human organism comprising a gene expression modulation system encoding a chimeric retinoid X receptor
#178MULTIPLE INDUCIBLE GENE REGULATION SYSTEM
#179Polynucleotide encoding an intracellular estradiol binding protein
#180Method of inactivating a glucocorticoid receptor gene in an isolated cell
#181Methods of using chimeric receptors to identify autoimmune disease
#182Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
#183Transgenic animals for assessing drug metabolism and toxicity
#184Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#185SYNERGISTIC ACTIVATION OF REGULATORY ELEMENTS BY REL PROTEINS AND A STEROID RECEPTOR
#186Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#187Diagnosis and treatment of endometriosis
#188Methods and Compositions for Modulating a Steroid Receptor
#189Heterocyclic selective androgen receptor modulators and methods of use thereof
#190Estrogen receptors and methods of use
#191Flea ultraspiracle nucleic acid molecules
#192Mutations in the mineralocorticoid receptor ligand binding domain polypeptide that permit structural determination of low affinity ligand complexes and screening methods employing same
#193OPIATE, CANNABINOID, AND ESTROGEN RECEPTORS
#194Steroid receptor modulation of gene expression
#195Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles
#196Delivery vehicle for recombinant proteins
#197Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing same
#198Characterization of a membrane estrogen receptor
#199WSX receptor agonist antibodies
#200Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
#201Crystallized structure of estrogen related receptor gamma in complex with bisphenol A
#202Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
#203Bacterial ligand-binding sensor
#204Mta1s, a steriod hormone receptor corepressor
#205G-protein estrogen membrane receptor
#206Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
#207Methods for the design of estrogen receptor ligands
#208Method and kit for detecting a risk for diabetes or a metabolic syndrome
#209Estrogen receptor genes and utilization thereof
#210Characterization of a membrane estrogen receptor
#211Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#212Design of progesterone receptor ligands
#213Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof
#214Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
#215Isoforms of the human vitamin D receptor
#216Methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
#217Androgen receptor complex-associated protein
#218Recombinant prion-like genes and proteins and materials and methods comprising the same
#219Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof
#220Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods
#221Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof
#222Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
#223Androgen receptor coactivators
#224CHARACTERIZATION OF A MEMBRANE ESTROGEN RECEPTOR
#225Treating androgen decline in aging male (ADAM)-associated conditions with SARMS
#226DNA encoding androgen receptor fragment
#227WSX receptor agonist antibodies
#228Intracellular estradiol binding protein